CrossrefInfokarte
Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data
Clinical Nephrology · 2022-05-01 · 97 (5) · 261-272
DOI: 10.5414/cn110516 ↗Abstract
Kein Abstract verfügbar.
EUVIMED